EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single‐Arm Meta‐Analysis

Matteo Castrichini, Iuri Ferreira Felix iD, Vanessa Karlinski Vizentin, Ramin Garmany, Trung Huynh, Ikram U Haq, Will H Swain, Konstantinos C Siontis, Ammar M Killu, Abhishek J Deshmukh, Michael J Ackerman, John R Giudicessi

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70193 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Matteo Castrichini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (Division of Heart Rhythm Services), Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Lamin Type A, Cardiomyopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ventricular tachycardia (VT) is a life‐threatening arrhythmia frequently observed in structural heart diseases, including LMNA‐related cardiomyopathy, a genetic disorder associated with high risk of sudden cardiac death and progressive systolic dysfunction. While catheter ablation is an established therapeutic option for VT, its efficacy in cardiac laminopathy remains poorly defined.

Objectives

To synthesize available evidence on the role and outcomes of VT ablation in patients with cardiac laminopathy.

Methods

A systematic review and single‐arm meta‐analysis was performed in accordance with PRISMA guidelines. PubMed, Embase, and Cochrane databases were searched for studies reporting VT ablation outcomes in LMNA‐related cardiomyopathy. An inverse variance random‐effects model was applied for meta‐analysis of proportions.

Results

Seven studies (six cohorts, one abstract) comprising 62 patients (mean age 53.2 ± 9.7 years; 85% male; 88% with implantable cardioverter‐defibrillator) were included. An endocardial/endo‐epicardial approach was used in 93% of cases. Acute procedural success was achieved in 37% (95% CI: 14%–63%; I² = 27.4%), and 28% required multiple procedures. Over a median follow‐up of 26 (9–35) months, VT recurrence occurred in 91% (95% CI: 76%–100%; I² = 37.2%). All‐cause mortality was 54% (95% CI: 39%–70%; I² = 28%), predominantly from cardiac causes (51%, 95% CI: 25%–76%; I² = 53%), and 14% (95% CI: 1%–34%; I² = 42%) underwent heart transplantation.

Conclusions

In LMNA‐related cardiomyopathy, catheter ablation is associated with high VT recurrence, limited long‐term success, and substantial cardiovascular mortality and transplantation rates, underscoring the importance of ICD implantation and the need for alternative strategies, including variant‐specific and molecularly targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCatheter AblationLamin Type ACardiomyopathiesHumansMiddle AgedMaleFemaleRisk FactorsTreatment OutcomeTime FactorsRecurrenceAdultAction PotentialsHeart RateAged

Stichwörter der Autor:innen

arrhythmogenic cardiomyopathycatheter ablationlaminopathyventricular tachycardia

Substanzen

Lamin Type ALMNA protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine (Division of Heart Rhythm Services), Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Cardiac Death Genomics Laboratory), Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Mayo Clinic Medical Scientist Training Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.
  • Department of Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Iuri Ferreira Felix

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Castrichini, M., Ferreira Felix, I., Karlinski Vizentin, V., Garmany, R., Huynh, T., Haq, I. U., Swain, W. H., Siontis, K. C., Killu, A. M., Deshmukh, A. J., Ackerman, M. J., & Giudicessi, J. R. (2026). Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single‐Arm Meta‐Analysis. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70193

Vancouver

Castrichini M, Ferreira Felix I, Karlinski Vizentin V, Garmany R, Huynh T, Haq IU, et al. Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single‐Arm Meta‐Analysis. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70193

BibTeX
@article{Castrichini2026,
  author = {Castrichini, Matteo and Ferreira Felix, Iuri and Karlinski Vizentin, Vanessa and Garmany, Ramin and Huynh, Trung and Haq, Ikram U and Swain, Will H and Siontis, Konstantinos C and Killu, Ammar M and Deshmukh, Abhishek J and Ackerman, Michael J and Giudicessi, John R},
  title = {Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single‐Arm Meta‐Analysis},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70193}
}
Kostenlos starten →